InnoCare Pharma Limited (SHA:688428)
China flag China · Delayed Price · Currency is CNY
23.98
-0.55 (-2.24%)
At close: Jun 5, 2025, 2:57 PM CST

InnoCare Pharma Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
6,3276,2418,2878,7435,9293,970
Upgrade
Short-Term Investments
---313.29--
Upgrade
Trading Asset Securities
681.19759.18--317.06-
Upgrade
Cash & Short-Term Investments
7,0087,0008,2879,0566,2463,970
Upgrade
Cash Growth
-14.56%-15.53%-8.49%45.00%57.34%67.35%
Upgrade
Accounts Receivable
363.57351276.38127.8245.270.15
Upgrade
Other Receivables
0.270.0531.340.9962.2778.1
Upgrade
Receivables
363.83351.05307.71128.82107.5578.25
Upgrade
Inventory
97.0795.58119.0965.329.921.88
Upgrade
Other Current Assets
428.46373.5651.3849.3753.8742.46
Upgrade
Total Current Assets
7,8977,8208,7659,3006,4174,092
Upgrade
Property, Plant & Equipment
797.07814.27798.5681.5566.08403.13
Upgrade
Long-Term Investments
0.480.45.6611.71326.11.16
Upgrade
Goodwill
3.123.123.123.123.133.13
Upgrade
Other Intangible Assets
255.97258.14266.03273.1434.1737.02
Upgrade
Long-Term Deferred Charges
-31.9433.339.82--
Upgrade
Other Long-Term Assets
459.53479.4348.0619.7750.951.05
Upgrade
Total Assets
9,4149,4079,92010,3297,3984,538
Upgrade
Accounts Payable
165.68128.36134.9118.684.65.52
Upgrade
Accrued Expenses
41.17127.52100.06119.4697.550.21
Upgrade
Short-Term Debt
80.06137.45----
Upgrade
Current Portion of Long-Term Debt
95.4956.351,2561,197--
Upgrade
Current Portion of Leases
-31.6123.2320.1120.346.83
Upgrade
Current Unearned Revenue
---4.2419.486.65
Upgrade
Other Current Liabilities
583.21567.99567.66608.09107.3935.25
Upgrade
Total Current Liabilities
1,0071,0492,0822,068329.3104.45
Upgrade
Long-Term Debt
1,3441,322331.88287.761,2381,150
Upgrade
Long-Term Leases
25.2127.4443.6535.4447.4417.17
Upgrade
Long-Term Unearned Revenue
270.74263281.78293.58123.61100
Upgrade
Long-Term Deferred Tax Liabilities
-----6.04
Upgrade
Total Liabilities
2,6482,6622,7392,6841,7391,377
Upgrade
Common Stock
0.020.020.020.020.020.02
Upgrade
Additional Paid-In Capital
-12,11112,15012,0829,3726,743
Upgrade
Retained Earnings
-5,502-5,520-5,080-4,448-3,536-3,544
Upgrade
Treasury Stock
-9.01-3.1----
Upgrade
Comprehensive Income & Other
12,260137.9977.23-36.31-230.85-95.05
Upgrade
Total Common Equity
6,7496,7257,1487,5975,6053,104
Upgrade
Minority Interest
17.1420.6332.8647.2354.3656.49
Upgrade
Shareholders' Equity
6,7666,7467,1817,6445,6593,161
Upgrade
Total Liabilities & Equity
9,4149,4079,92010,3297,3984,538
Upgrade
Total Debt
1,5451,5751,6551,5401,3061,174
Upgrade
Net Cash (Debt)
5,4635,4256,6327,5164,9402,796
Upgrade
Net Cash Growth
-29.89%-18.20%-11.76%52.15%76.67%-
Upgrade
Net Cash Per Share
3.223.203.895.093.622.89
Upgrade
Filing Date Shares Outstanding
1,7971,7621,7631,7641,5001,289
Upgrade
Total Common Shares Outstanding
1,7971,7621,7631,7641,5001,289
Upgrade
Working Capital
6,8906,7716,6837,2326,0883,988
Upgrade
Book Value Per Share
3.763.824.054.313.742.41
Upgrade
Tangible Book Value
6,4906,4646,8797,3215,5673,064
Upgrade
Tangible Book Value Per Share
3.613.673.904.153.712.38
Upgrade
Buildings
-422.73364.63224.4181.04-
Upgrade
Machinery
-362.86302.01248.14127.5713.91
Upgrade
Construction In Progress
-138.86166.91197.65230.72296.93
Upgrade
Leasehold Improvements
----6.681.08
Upgrade
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.